Advertisement

Neurobehavioral Complications of HIV Infection

  • Thomas D. Marcotte
  • Igor Grant
  • J. Hampton Atkinson
  • Robert K. Heaton
Part of the Critical Issues in Neuropsychology book series (CINP)

Abstract

It is estimated that 34.3 million people worldwide are now living with human immunodeficiency virus (HIV) infection (United Nations Programme on HIV/AIDS & World Health Organization, 2000), a retrovirus that causes acquired immunodeficiency syndrome (AIDS). Since the beginning of the HIV pandemic, almost 19 million individuals have died from AIDS (2.8 million of these in 1999). Despite significant medical advances in the treatment of the disease, the rate at which individuals are becoming infected continues to increase. Close to 6 million new individuals were infected in 1998, primarily in the developing world (see Table 1). Sub-Saharan African countries are the most profoundly impacted, with up to one quarter of young adults being HIV seropositive.

Keywords

Human Immunodeficiency Virus Human Immunodeficiency Virus Infection Human Immunodeficiency Virus Disease Multicenter AIDS Cohort Study Human Immunodeficiency Virus Dementia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adams, R. L., Boake, C., & Crain, C. (1982). Bias in neuropsychological test classification related to education, age, and ethnicity. Journal of Consulting and Clinical Psychology, 50, 143–145.PubMedGoogle Scholar
  2. Albert, S. M., Marder, K. M., Dooneief, G., Bell, K., Sano, M., Todak, G., & Stem, Y. (1995). Neuropsychologic impairment in early HIV infection: A risk factor for work disability. Archives of Neurology,52, 525–530.PubMedGoogle Scholar
  3. Albert, S. M., Weber, C. M., Todak, G., Polanco, C., Clouse, R., McElhiney, M., Rabkin, J., Stern, Y., & Marder, K. (1999). An observed performance test of medication management ability in HIV: Relation to neuropsychological status and medication adherence outcomes. AIDS and Behavior, 3(2),121–128.Google Scholar
  4. American Academy of Neurology. (1998). Evaluation and management of intracranial mass lesions in AIDS. Report of the Quality Standards Subcommittee of the American Academy of Neurology.Neurology, 50, 21–26.Google Scholar
  5. American Academy of Neurology AIDS Task Force. (1991). Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Neurology, 41, 778–785.Google Scholar
  6. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4thed.). Washington, DC: Author.Google Scholar
  7. Atkinson, J. H., & Grant, I. (1994). Natural history of neuropsychiatric manifestations of HIV disease.Psychiatric Clinics of North America, 17(1), 17–33.PubMedGoogle Scholar
  8. Atkinson, J. H., & Grant, I. (1997). Neuropsychiatry of human immunodeficiency virus infection. In J. R. Berger & R. M. Levy (Eds.), AIDS and the nervous system (2nd ed., pp. 419–449). Philadelphia:Lippincott-Raven.Google Scholar
  9. Atkinson, J. H., Jr., Grant, I., Kennedy, C. J., Richman, D. D., Spector, S. A., & McCutchan, J. A. (1988).Prevalence of psychiatric disorders among men infected with human immunodeficiency virus. A controlled study. Archives of General Psychiatry, 45, 859–864.PubMedGoogle Scholar
  10. Bacellar, H., Muñoz, A., Miller, E. N., Cohen, B. A., Besley, D., Seines, O. A., Becker, J. T., & McArthur,J. C. (1994). Temporal trends in the incidence of HIV-1-related neurologic diseases: Multicenter AIDS Cohort Study, 1985–1992. Neurology, 44, 1892–1900.PubMedGoogle Scholar
  11. Baldeweg, T., Catalan, J., Lovett, E., Gruzelier, J., Riccio, M., & Hawkins, D. (1995). Long-term zidovudine reduces neurocognitive deficits in HIV-1 infection. AIDS, 9, 589–596.PubMedGoogle Scholar
  12. Bamborschke, S., Wullen, T., Huber, M., Neveling, M., Baldamus, C. A., Korn, K., & Jahn, G. (1992). Early diagnosis and successful treatment of acute cytomegalovirus encephalitis in a renal transplant-recipient. Journal of Neurology, 239, 205–208.PubMedGoogle Scholar
  13. Becker, J. T., Caldararo, R., Lopez, O. L., Dew, M. A., Dorst, S. K., & Banks, G. (1995). Qualitative features of the memory deficit associated with HIV infection and AIDS: Cross-validation of a discriminant function classification scheme. Journal of Clinical and Experimental Neuropsychology, 17,134–142.PubMedGoogle Scholar
  14. Bloom, F. E., & Rausch, D. M. (1997). HIV in the brain: Pathology and neurobehavioral consequences (meeting report). Journal of Neurovirology, 3, 102–109.PubMedGoogle Scholar
  15. Bornstein, R. A., Nasrallah, H. A., Para, M. F., Fass, R. J., Whitacre, C. C., & Rice, R. R. (1991). Rate of CD4 decline and neuropsychological performance in HIV infection. Archives of Neurology, 48, 704–707.PubMedGoogle Scholar
  16. Bornstein, R. A., Nasrallah, H. A., Para, M. F., Whitacre, C. C., Rosenberger, P., Fass, R. J., & Rice, R.(1992). Neuropsychological performance in asymptomatic HIV infection. Journal of Neuropsychiatry and Clinical Neurosciences, 4, 386–394.PubMedGoogle Scholar
  17. Brew, B. J., Rosenblum, M., Cronin, K., & Price, R. W. (1995). AIDS dementia complex and HIV-1 brain infection: Clinical-virological correlations. Annals of Neurology, 38, 563–570.PubMedGoogle Scholar
  18. Brown, G. R. (1995). The use of methylphenidate for cognitive decline associated with HIV disease.International Journal of Psychiatry in Medicine, 25(1), 21–37.PubMedGoogle Scholar
  19. Brown, G. R., Rundell, J. R., McManis, S. E., Kendall, S. N., Zachary, R., & Temoshok, L. (1992).Prevalence of psychiatric disorders in early stages of HIV infection. Psychosomatic Medicine, 54,588–601.PubMedGoogle Scholar
  20. Butters, N., Grant, I., Haxby, J., Judd, L. L., Martin, A., McClelland, J., Pequegnat, W., Schacter, D., & Stover, E. (1990). Assessment of AIDS-related cognitive changes: Recommendations of the NIMH Workshop on Neuropsychological Assessment Approaches. Journal of Clinical and Experimental Neuropsychology, 12, 963–978.PubMedGoogle Scholar
  21. Bylsma, S. S., Achim, C. L., Wiley, C. A., Gonzalez, C., Kuppermann, B. D., Berry, C., & Freeman, W. R.(1995). The predictive value of cytomegalovirus retinitis for cytomegalovirus encephalitis in acquired immunodeficiency syndrome. Archives of Ophthalmology, 113(1), 89–95.PubMedGoogle Scholar
  22. Carlin, A. S., & O’Malley, S. (1997). Neuropsychological consequences of drug abuse. In I. Grant & K. M.Adams (Eds.), Neuropsychological assessment of neuropsychiatric disorders (2nd ed., pp. 486–503). New York: Oxford University Press.Google Scholar
  23. Centers for Disease Control. (1999). HIV/AIDS surveillance report (Vol. 11, p. 30).Google Scholar
  24. Chelune, G., & Moehle, K. (1986). Neuropsychological assessment and everyday functioning. In D.Wedding, J. Horton, & J. Webster (Eds.), The neuropsychology handbook: Behavioral and clinical perspectives (pp. 489–525). New York: Springer.Google Scholar
  25. Clifford, D. B., Yiannoutsos, C., Glicksman, M., Simpson, D. M., Singer, E. J., Piliero, P. J., Marra, C. M.,Francis, G. S., McArthur, J. C., Tyler, K. L., Tselis, A. C., & Hyslop, N. E. (1999). HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy [see comments]. Neurology, 52(3), 623–625.PubMedGoogle Scholar
  26. Cournos, F., & McKinnon, K. (1997). HIV seroprevalence among people with severe mental illness in the United States: A critical review. Clinical Psychology Review, 17, 259–269.PubMedGoogle Scholar
  27. Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders. (1997). Safety and tolerability of the antioxidant OPC-14117 in HIV-associated cognitive impairment. Neurology, 49,142–146.Google Scholar
  28. Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders. (1998). A randomized, double-blind, placebo-controlled trial of deprenyl and thioctic acid in human immunodeficiency virus-associated cognitive impairment. Neurology, 50, 645–651.Google Scholar
  29. Day, J. J., Grant, I., Atkinson, J. H., Brysk, L. T., McCutchan, J. A., Hesselink, J. R., Heaton, R. K.,Weinrich, J. D., Spector, S. A., & Richman, D. D. (1992). Incidence of AIDS dementia in a two-year follow-up of AIDS and ARC patients on an initial phase IIAZT placebo-controlled study: San Diegocohort. Journal of Neuropsychiatry and Clinical Neuroscience, 4, 15–20.Google Scholar
  30. Dew, M. A., Ragni, M. V., & Nimorwicz, P. (1990). Infection with human immunodeficiency virus and vulnerability to psychiatric distress: A study of men with hemophilia. Archives of General Psychiatry, 47, 737–744.PubMedGoogle Scholar
  31. Dew, M. A., Becker, J. T., Sanchez, J., Caldararo, R., Lopez, O. L., Wess, J., Dorst, S. K., & Banks, G. (1997).Prevalence and predictors of depressive, anxiety and substance use disorders in HIV-infected and uninfected men: A longitudinal evaluation. Psychological Medicine, 27, 395–409.PubMedGoogle Scholar
  32. Dore, G. J., Correll, P. K., Li, Y., Kaldor, J. M., Cooper, D. A., & Brew, B. J. (1999). Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS, 13, 1249–1253.PubMedGoogle Scholar
  33. Dragic, T., Litwin, V., Allaway, G. P., Martin, S. R., Huang, Y., Nagashima, K. A., Cayanan, C., Maddon, P.J., Koup, R. A., Moore, J. P., & Paxton, W. A. (1996). HIV-1 entry into CD4 + cells is mediated by the chemokine receptor CC-CKR-5 [see comments]. Nature, 381, 667–673.PubMedGoogle Scholar
  34. Ellis, R. J., Deutsch, R., Heaton, R. K., Marcotte, T. D., McCutchan, J. A., Nelson, J. A., Abramson, I., Thai,L., Atkinson, J. H., Wallace, M. R., Grant, I., & the HNRC Group. (1997a). Neurocognitive impairment is an independent risk factor for death in HIV infection. Archives of Neurology, 54, 416–424.PubMedGoogle Scholar
  35. Ellis, R. J., Hsia, K., Spector, S. A., Nelson, J. A., Heaton, R. K., Wallace, M. R., Abramson, I., Atkinson, J.H., Grant, I., McCutchan, J. A., & the HNRC Group. (1997b). Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. Annals of Neurology, 42, 679–688.PubMedGoogle Scholar
  36. Evans, D. L., Leserman, J., Perkins, D. O., Stern, R. A., Murphy, C., Zheng, B., Gettes, D., Longmate, J. A.,Silva, S. G., van der Horst, C. M., Hall, C. D., Folds, J. D., Golden, R. N., & Petitto, J. M. (1997). Severe life stress as a predictor of early disease progression in HIV infection. American Journal of Psychiatry, 154, 630–634.PubMedGoogle Scholar
  37. Everall, I. P., Luthert, P. J., & Lantos, P. L. (1991). Neuronal loss in the frontal cortex in HIV infection.Lancet, 337, 1119–1121.PubMedGoogle Scholar
  38. Feng, Y., Broder, C. C., Kennedy, P. E., & Berger, E. A. (1996). HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor [see comments]. Science, 272,872–877.PubMedGoogle Scholar
  39. Fernandez, F., Adams, F., Levy, J. K., Holmes, V., Neidhart, M., & Mansell, P. W. A. (1988). Cognitive impairment due to AIDS-related complex and its response to psychostimulants. Psychosomatics,29, 38–46.PubMedGoogle Scholar
  40. Ferrando, S., van Gorp, W., McElhindy, M., Goggin, K., Sewell, M., & Rabkin, J. (1998). Highly active antiretroviral treatment in HIV infection: Benefits for neuropsychological function. AIDS, 12,F65–F70.PubMedGoogle Scholar
  41. Galgani, S., Balestra, P., Narciso, P., Tozzi, V., Sette, P., Pau, F., & Visco, G. (1997). Nimodipine plus zidovudine versus zidovudine alone in the treatment of HIV-1-associated cognitive deficits. AIDS,11, 1520–1521.PubMedGoogle Scholar
  42. Gillespie, S. M., Chang, Y., Lemp, G., Arthur, R., Buchbinder, S., Steimle, A., Baumgartner, J., Rando, T.,Neal, D., Rutherford, G., Schonberger, L., & Janssen, R. (1991). Progressive multifocal leukoencephalopathy in persons infected with human immunodeficiency virus, San Francisco, 1981–1989.Annals of Neurology, 30, 597–604.PubMedGoogle Scholar
  43. Glass, J. D., Wesselingh, S. L., Seines, O. A., & McArthur, J. C. (1993). Clinical-neuropathologic correlations in HIV-associated dementia. Neurology, 43, 2230–2237.PubMedGoogle Scholar
  44. Goggin, K. J., Zisook, S., Heaton, R. K., Atkinson, J. H., Marshall, S., McCutchan, J. A., Chandler, J. L.,Grant, I., & the HNRC Group. (1997). Neuropsychological performance of HIV-1 infected men with major depression. Journal of the International Neuropsychological Society, 3, 457–464.PubMedGoogle Scholar
  45. Grant, I., & Atkinson, J. H. (1995). Psychiatric aspects of acquired immunodeficiency syndrome. In H. I.Kaplen & B. J. Sadock (Eds.), Comprehensive textbook of psychiatry/VI (Vol. VI, pp. 1644–1669).Baltimore: Williams & Williams.Google Scholar
  46. Grant, I., Adams, K. M., Carlin, A. S., Rennick, P., Judd, L. L., & Schooff, K. (1978). The collaborative neuropsychological study of polydrug abusers. Archives of General Psychiatry, 35, 1063–1074.Google Scholar
  47. Grant, I., Atkinson, J. H., Hesselink, J. R., Kennedy, C. J., Richman, D. D., Spector, S. A., & McCutchan, J.A. (1987). Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Annals of Internal Medicine, 107, 828–836.PubMedGoogle Scholar
  48. Grant, I., Olshen, R. A., Atkinson, J. H., Heaton, R. K., Nelson, J., McCutchan, J. A., & Weinrich, J. D.(1993). Depressed mood does not explain neuropsychological deficits in HIV-infected persons.Neuropsychology, 7(1), 53–61.Google Scholar
  49. Grant, I., Heaton, R. K., Atkinson, J. H., & the HNRC Group. (1995). Neurocognitive disorder in HIV-1infection. In M. B. A. Oldstone & L. Vitkovic (Eds.), Current topics in microbiology and immunology. HIV and dementia (Vol. 202, pp. 9–30). Heidelberg: Springer-Verlag.Google Scholar
  50. Harris, M. J., Jeste, D. V., Gleghorn, A., & Sewell, D. D. (1991). New-onset psychosis in HIV-infected patients [see comments]. Journal of Clinical Psychiatry, 52(9), 369–376.PubMedGoogle Scholar
  51. Haverkos, H. W., Turner Jr., J. F., Moolchan, E. T., & Cadet, J. L. (1999). Relative rates of AIDS amongracial/ethnic groups by exposure categories. Journal of the National Medical Association, 91(1),17–24.PubMedGoogle Scholar
  52. Heaton, R. K. (1992). Comprehensive norms for an expanded Halstead-Reitan Battery: A supplement for the WAIS-R. Odessa, FL: Psychological Assessment Resources, Inc.Google Scholar
  53. Heaton, R. K., Grant, I., & Matthews, C. G. (1991). Comprehensive norms for an expanded Halstead-Reitan Battery: Demographic corrections, research findings, and clinical applications. Odessa, FL:Psychological Assessment Resources, Inc.Google Scholar
  54. Heaton, R. K., Velin, R. A., McCutchan, J. A., Gulevich, S. J., Atkinson, J. H., Wallace, M. R., Godfrey, H.P. D., Kirson, D. A., Grant, I., & the HNRC Group. (1994). Neuropsychological impairment in human immunodeficiency virus-infection: Implications for employment. Psychosomatic Medicine, 56(1),8–17.PubMedGoogle Scholar
  55. Heaton, R. K., Grant, I., Butters, N., White, D. A., Kirson, D., Atkinson, J. H., McCutchan, J. A., Taylor, M.J., Kelly, M. D., Ellis, R. J., Wolfson, T., Velin, R., Marcotte, T. D., Hesselink, J. R., Jernigan, T. L.,Chandler, J., Wallace, M., Abramson, I., & the HNRC Group. (1995). The HNRC 500-Neuropsychology of HIV infection at different disease stages. Journal of the International Neuropsychological Society, 1, 231–251.PubMedGoogle Scholar
  56. Heaton, R. K., Marcotte, T. D., Ellis, R. J., Deutsch, R., Abramson, I., Grant, I., & the HNRC Group. (1996a).Neuropsychological profile and prognostic significance of Minor Cognitive/Motor Disorder [Ab-stract]. Journal of Neurovirology, 2, 39.Google Scholar
  57. Heaton, R. K., Marcotte, T. D., White, D. A., Ross, D., Meredith, K., Taylor, M. J., Kaplan, R., & Grant, I.(1996b). Nature and vocational significance of neuropsychological impairment associated with HIV infection. Clinical Neuropsychologist, 10, 1–14.Google Scholar
  58. Heseltine, P. N. R., Goodkin, K., Atkinson, J. H., Vitiello, B., Rochon, J., Heaton, R. K., Eaton, E. M.,Wilkie, F. L., Sobel, E., Brown, S. J., Feaster, D., Schneider, L., Goldschmidts, W. L., & Stover, E. S.(1998). Randomized double-blind placebo-controlled trial of peptide-T for HIV-associated cognitive impairment. Archives of Neurology, 55, 41–51.PubMedGoogle Scholar
  59. Heyes, M., Brew, B., Martin, A., Price, R., Salazar, A., Sidtis, J., Yergey, J., Mouradian, M., Sadler, A.,Keilp, J., Rubinow, D., & Markey, S. (1991). Quinolinic acid in cerebrospinal fluid and serum in HIV infection: Relationship to clinical and neurologic status. Annals of Neurology, 29, 202–209.PubMedGoogle Scholar
  60. Hinkin, C. H., van Gorp, W. G., Satz, P., Weisman, J. D., Thommes, J., & Buckingham, S. (1992).Depressed mood and its relationship to neuropsychological test performance in HIV-1 seropositive individuals. Journal of Clinical and Experimental Neuropsychology, 14, 289–297.PubMedGoogle Scholar
  61. Hinkin, C. H., Castellon, S. A., Hardy, D. J., Granholm, E., & Siegle, G. (1999). Computerized and traditional Stroop task dysfunction in HIV-1 infection. Neuropsychology, 13, 306–316.PubMedGoogle Scholar
  62. Holland, N., Power, C., Matthews, V., Glass, J., Forman, M., & McArthur, J. (1994). Cytomegalovirus encephalitis in acquired immunodeficiency syndrome (AIDS). Neurology, 44, 892–900.Google Scholar
  63. Ickovics, J. R., & Rodin, J. (1992). Women and AIDS in the United States: Epidemiology, natural history,and mediating mechanisms. Health Psychology, 11(1), 1–16.PubMedGoogle Scholar
  64. Inouye, S. K., Albert, M. S., Mohs, R., Sun, K., & Berkman, L. F. (1993). Cognitive performance in a high-functioning community-dwelling elderly population. Journal of Gerontology, 48, M146–M151.PubMedGoogle Scholar
  65. Janssen, R. S., Okey, C. N., Selik, R. M., & Stehr-Green, J. K. (1992). Epidemiology of human immunodeficiency virus encephalopathy in the United States. Neurology, 42, 1472–1476.PubMedGoogle Scholar
  66. Jarvik, J. G., Lenkinski, R. E., Grossman, R. I., Gomory, J. M., Schnall, M. D., & Frank, I. (1993). Proton MR spectroscopy of HIV-infected patients: Characterization of abnormalities with imaging and clinical correlation. Radiology, 186, 739–744.PubMedGoogle Scholar
  67. Jarvik, J. G., Lenkinski, R. E., Saykin, A. J., Jaans, A., & Frank, I. (1996). Proton spectroscopy in asymptomatic HIV-infected adults: Initial results in a prospective cohort study. Journal of AcquiredImmune Deficiency Syndromes and Human Retrovirology, 13, 247–253.Google Scholar
  68. Jernigan, T. L., Archibald, S., Hesselink, J. R., Atkinson, J. H., Velin, R. A., McCutchan, J. A., Chandler, J.,Grant, I., & the HNRC Group. (1993). Magnetic resonance imaging morphometric analysis of cerebral volume loss in human immunodeficiency virus infection. Archives of Neurology, 50, 250–255.PubMedGoogle Scholar
  69. Kaplan, R. M., Anderson, J. P., Patterson, T. L., McCutchan, J. A., Weinrich, J. D., Heaton, R. K., Atkinson,J. H., Thai, L., Chandler, J., Grant, I., & the HNRC Group. (1995). Validity of the Quality of Well-Being Scale for persons with human immunodeficiency virus infection. Psychosomatic Medicine, 57,138–147.PubMedGoogle Scholar
  70. Kaufman, A. S., McClean, J. E., & Reynolds, C. R. (1988). Sex, race, residence, region, and education differences on the 11 WAIS-R subtests. Journal of Clinical Psychology, 44, 231–248.PubMedGoogle Scholar
  71. Lei, S. Z., Zhang, D., Abele, A. E., & Lipton, S. A. (1992). Blockade of NMDA receptor-mediated mobilization of intracellular Ca prevents neurotoxicity. Brain Research, 598, 196–202.PubMedGoogle Scholar
  72. Leserman, J., Petitto, J. M., Perkins, D. O., Folds, J. D., Golden, R. N., & Evans, D. L. (1997). Severe stress,depressive symptoms, and changes in lymphocyte subsets in human immunodeficiency virus-infected men. A 2-year follow-up study. Archives of General Psychiatry, 54, 279–285.PubMedGoogle Scholar
  73. Letendre, S., Ellis, R., Heaton, R. K., Atkinson, J. H., Nelson, J., Grant, I., & McCutchan, J. A. (1998).Change in CSF RNA level correlates with effects of antiretroviral therapy on HIV-1 associated neurocognitive disorder [Abstract]. Journal of Neurovirology, 4, 357.Google Scholar
  74. Lipton, S. A., & Rosenberg, P. A. (1994). Excitatory amino acids as a final common pathway for neurologic disorders. New England Journal of Medicine, 330, 613–622.PubMedGoogle Scholar
  75. Lyketsos, C. G., Hoover, D. R., Guccione, M., Dew, M. A., Wesch, J. E., Bing, E. G., & Treisman, G. J. (1996).Changes in depressive symptoms as AIDS develops. The Multicenter AIDS Cohort Study. American Journal of Psychiatry, 153, 1430–1437.PubMedGoogle Scholar
  76. Maj, M. (1990). Psychiatric aspects of HIV-1 infection and AIDS. Psychological Medicine, 20, 547–563.PubMedGoogle Scholar
  77. Maj, M., Satz, P., Janssen, R., Zaudig, M., Starace, F., D’Elia, L., Sughondhabirom, B., Mussa, M., Naber,D., & Ndetei, D. (1994). WHO Neuropsychiatric AIDS study, cross-sectional phase II. Neuropsy-chological and neurological findings. Archives of General Psychiatry, 51, 51–61.PubMedGoogle Scholar
  78. Marcotte, T. D., Heaton, R. K., Wolfson, T., Taylor, M. J., Alhassoon, O., Arfaa, K., Ellis, R. J., Grant, I., & the HNRC Group. (1999). The impact of HIV-related neuropsychological dysfunction on driving behavior. Journal of the International Neuropsychological Society, 5, 579–592.PubMedGoogle Scholar
  79. Martin, E. M., Robertson, L., Edelstein, H., Jagust, W., & Sorensen, D. J. (1992a). Performance of patients with early HIV-1 infection on the Stroop task. Journal of Clinical and Experimental Neuropsychology, 14, 857–868.PubMedGoogle Scholar
  80. Martin, E. M., Sorensen, D. J., Edelstein, H. E., & Robertson, L. C. (1992b). Decision-making speed in early HIV-1 infection: A preliminary report. AIDS, 6, 109–113.PubMedGoogle Scholar
  81. Martin, E. M., Sorensen, D. J., Robertson, L. C., Edelstein, H. E., & Chirurgi, V. A. (1992c). Spatialattention in HIV-1 infection: A preliminary report. Journal of Neuropsychiatry and Clinical Neuro-sciences, 4, 1–6.Google Scholar
  82. Martin, E. M., Robertson, L. C, Edelstein, H. E., Jagust, W. J., Sorensen, D. J., San Giovanni, D., &Chirurgi, V. A. (1993). Speed of memory scanning is not affected in early HIV-1 infection. Journal of Clinical and Experimental Neuropsychology, 15, 311–320.PubMedGoogle Scholar
  83. Martin, E. M., Cook, J. A., Cohen, M., Carson, V., Reed, R., Hershow, R., & Burke, J. (1999). Working memory function in HIV-seropositive women: The Women’s Interagency HIV Study [Abstract].Journal of the International Neuropsychological Society, 5, 155.Google Scholar
  84. Masliah, E., Achim, C. L., Ge, N., DeTeresa, R., Terry, R. D., & Wiley, C. A. (1992a). Spectrum of human immunodeficiency virus-associated neocortical damage. Annals of Neurology, 32, 321–329.PubMedGoogle Scholar
  85. Masliah, E., Ge, N., Morey, M., DeTeresa, R., Terry, R. D., & Wiley, C. A. (1992b). Cortical dendriticpathology in human immunodeficiency virus encephalitis. Laboratory Investigation, 66, 285–291.PubMedGoogle Scholar
  86. Masliah, E., Achim, C., DeTeresa, R., Ge, N., & Wiley, C. A. (1994). Cellular neuropathology in HIV encephalitis. In R. W. Price (Ed.), HIV, AIDS and the brain (pp. 119–131). New York: Raven Press.Google Scholar
  87. Masliah, E., Ge, N., Achim, C. L., & Wiley, C. A. (1996). Patterns of neurodegeneration in HIV encephalitis. Journal of Neuro-AIDS, 1(1), 161–173.PubMedGoogle Scholar
  88. Masliah, E., Heaton, R. K., Marcotte, T. D., Ellis, R. J., Wiley, C. A., Mallory, M., Achim, C. L.,McCutchan, J. A., Nelson, J. A., Atkinson, J. H., Grant, I., & the HNRC Group. (1997). Dendritic in jury is a pathologic substrate for HIV-related cognitive disorders. Annals of Neurology, 42, 963–972.PubMedGoogle Scholar
  89. Mayeux, R., Stern, Y., Tang, M.-X., Todak, G., Marder, K., Sano, J., Richards, M., Stein, Z., Ehrhardt, A., & Gorman, J. (1993). Mortality risks in gay men with human immunodeficiency virus infection and cognitive impairment. Neurology, 43, 176–182.PubMedGoogle Scholar
  90. McArthur, J. (1987). Neurologic manifestations of AIDS. Medicine (Baltimore), 66, 407–437.Google Scholar
  91. McArthur, J. C., & Grant, I. (1998). HIV neurocognitive disorders. In H. E. Gendelman, S. Lipton, L.Epstein, & S. Swindells (Ed.), Neurology of AIDS (pp. 499–524). New York: Chapman & Hall.Google Scholar
  92. McArthur, J. C., Cohen, B. A., Seines, O. A., Kumar, A. J., Cooper, K., McArthur, J. H., Soucy, G.,Cornblath, D. R., Chmiel, J. S., Wang, M., Starkey, D. L., Ginzburg, H., Ostrow, D. G., Johnson, R. T.,Phair, J. P., & Polk, B. F. (1989). Low prevalence of neurological and neuropsychological abnor-malities in otherwise healthy HIV-1 infected individuals: Results from the Multicenter AIDS Cohort Study. Annals of Neurology, 26, 601–611.PubMedGoogle Scholar
  93. McArthur, J. C., Hoover, D. R., Bacellar, H., Miller, E. N., Cohen, B. A., Becker, J. T., Graham, N. M. H., McArthur, J. H., Seines, O. A., Jacobson, L. P., Visscher, B. R., Concha, M., & Saah, A. (1993).Dementia in AIDS patients: Incidence and risk factors. Neurology, 42, 1707–1712.Google Scholar
  94. Mellors, J. W., Rinaldo, C. R., Gupta, P., White, R. M., Todd, J. A., & Kingsley, L. A. (1996). Prognosis of HIV-1 infection predicted by the quantity of virus in plasma. Science, 272, 1167–1170.PubMedGoogle Scholar
  95. Miller, E. N., Seines, O. A., McArthur, J. C., Satz, P., Becker, J. T., Cohen, B. A., Sheridan, K., Machado, A.M., Van Gorp, W. G., & Visscher, B. (1990). Neuropsychological performance in HIV-1 infected homosexual men: The Multicenter AIDS Cohort Study (MACS). Neurology, 40, 197–203.PubMedGoogle Scholar
  96. Miller, E., Satz, P., & Visscher, B. (1991). Computerized and conventional neuropsychological assessment of HIV-1 infected homosexual men. Neurology, 41, 1608–1616.PubMedGoogle Scholar
  97. Miller, E. N., Bing, E. G., Seines, O. A., Wesch, J., & Becker, J. T. (1993). The effects of sociodemographic factors on reaction time and speed of information processing [Abstract]. Journal of Clinical and Experimental Neuropsychology, 15, 66.Google Scholar
  98. Miller, S. W., Heaton, R. K., Kirson, D., & Grant, I. (1997). Neuropsychological assessment of African Americans [Abstract]. Journal of the International Neuropsychological Society, 3, 49.Google Scholar
  99. Navia, B. A., & Price, R. W. (1987). The acquired immunodeficiency syndrome dementia complex as the presenting or sole manifestation of human immunodeficiency virus infection. Archives of Neurology, 44, 65–69.PubMedGoogle Scholar
  100. Navia, B. A., Cho, E.-S., Petito, C. K., & Price, R. W. (1986a). The AIDS dementia complex: II. Neuro-pathology. Annals of Neurology, 19, 525–535.PubMedGoogle Scholar
  101. Navia, B. A., Jordan, B. D., & Price, R. W. (1986b). The AIDS dementia complex: I. Clinical features.Annals of Neurology, 19, 517–524.PubMedGoogle Scholar
  102. Navia, B. A., Dafni, U., Simpson, D., Tucker, T., Singer, E., McArthur, J. C., Yiannoutsos, C., Zaborski, L.,Lipton, S. A., & the AIDS Clinical Trial Group. (1998). A phase I/II trial of nimodipine for HIV-related neurologic complications. Neurology, 51, 221–228.PubMedGoogle Scholar
  103. Nordic Medical Research Council’s HIV Therapy Group. (1992). Double blind, dose-response study of zidovudine in AIDS and advance: HIV infection. British Medical Journal, 304, 13–17.Google Scholar
  104. Ostrow, D. G., Monjan, A., Joseph, J., VanRaden, M., Fox, R., Kingsley, L., Dudley, J., & Phair, J. (1989).HIV-related symptoms and psychological functioning in a cohort of homosexual men. American Journal of Psychiatry, 146, 737–742.PubMedGoogle Scholar
  105. Peavy, G., Jacobs, D., Salmon, D. P., Butters, N., Delis, D. C., Taylor, M., Massman, P., Stout, J. C., Heindel,W. G., Kirson, D., Atkinson, J. H., Chandler, J. L., & Grant, I. (1994). Verbal memory performance of patients with human immunodeficiency virus infection: Evidence of subcortical dysfunction.Journal of Clinical and Experimental Neuropsychology, 16, 508–523.PubMedGoogle Scholar
  106. Perdices, M. A., & Cooper, D. A. (1989). Simple and choice reaction time in patients with human immunodeficiency virus infection. Annals of Neurology, 25, 460–467.PubMedGoogle Scholar
  107. Perkins, D. O., Stern, R. A., Golden, R. N., Murphy, C., Naftolowitz, D., & Evans, D. L. (1994). Mood disorders in HIV infection: Prevalence and risk factors in a nonepicenter of the AIDS epidemic.American Journal of Psychiatry, 151, 233–236.PubMedGoogle Scholar
  108. Perry, S., Jacobsberg, L. B., Fishman, B., Frances, A., Bobo, J., & Jacobsberg, B. K. (1990). Psychiatric diagnosis before serological testing for the human immunodeficiency virus. American Journal of Psychiatry, 147, 89–93.PubMedGoogle Scholar
  109. Portegies, P., de Gans, J., Lange, J. M. A., Derix, M. M. A., Speelman, H., Bakker, M., Danner, S. A., & Goudsmit, J. (1989). Declining incidence of AIDS dementia complex after introduction of zidovudine treatment. British Medical Journal, 299, 819–821.PubMedGoogle Scholar
  110. Post, M. J. D., Berger, J. R., & Qeuncer, R. M. (1991). Asymptomatic and neurologically symptomatic HIV-seropositive individuals: Prospective evaluation with cranial MR imaging. Radiology, 178,131–139.PubMedGoogle Scholar
  111. Price, R. W., & Brew, B. J. (1988). The AIDS dementia complex. Journal of Infectious Diseases, 158, 1079–1083.PubMedGoogle Scholar
  112. Prevalence of psychiatric disorders in HIV illness. International Review of Psychiatry, 8, 157–166.Google Scholar
  113. Rabkin, J. G., & Ferrando, S. (1997). A “second life” agenda. Psychiatric research issues raised by protease inhibitor treatments for people with the human immunodeficiency virus or the acquired immunodeficiency syndrome. Archives of General Psychiatry, 54, 1049–1053.PubMedGoogle Scholar
  114. Rabkin, J. G., Goetz, R. R., Remien, R. H., Williams, J. B., Todak, G., & Gorman, J. M. (1997a). Stability of mood despite HIV illness progression in a group of homosexual men [see comments]. American Journal of Psychiatry, 154, 231–238.PubMedGoogle Scholar
  115. Rabkin, J. G., Johnson, J., Lin, S. H., Lipsitz, J. D., Remien, R. H., Williams, J. B., & Gorman, J. M. (1997b).Psychopathology in male and female HIV-positive and negative injecting drug users: Longitudinal course over 3 years. AIDS, 11, 507–515.PubMedGoogle Scholar
  116. Reed, G. M., Kemeny, M. E., Taylor, S. E., & Visscher, B. R. (1999). Negative HIV-specific expectancies and AIDS-related bereavement as predictors of symptom onset in asymptomatic HIV-positive gaymen. Health Psychology, 18, 354–363.PubMedGoogle Scholar
  117. Reicks, C. J., Moore, D. J., Dawson, L. K., Marcotte, T. D., Heaton, R. K., Grant, I., & the HNRC Group.(1999). Neuropsychological performance predicts everyday functioning in HIV + individuals [Abstract]. Journal of the International Neuropsychological Society, 5, 155.Google Scholar
  118. Rosenberger, P. H., Bornstein, R. A., Nasrallah, H. A., Para, M. F., Whitaker, C. C., Fass, R. J., & Rice, R. R.,Jr. (1993). Psychopathology in human immunodeficiency virus infection: Lifetime and current assessment. Comprehensive Psychiatry, 34(3), 150–158.PubMedGoogle Scholar
  119. Rosenblum, M. L., Levy, R. M., Bredesen, D. E., So, Y. T., Wara, W., & Ziegler, J. L. (1988). Primary central nervous system lymphomas in patients with AIDS. Annals of Neurology, 23, S13–S16.PubMedGoogle Scholar
  120. Rottenberg, D. A., Moeller, J. R., Strother, S. C., Sidtis, J. J., Navia, B. A., Dhawan, V., Ginos, Z., & Price, R.W. (1987). The metabolic pathology of the AIDS dementia complex. Annals of Neurology, 22,700–706.PubMedGoogle Scholar
  121. Rounsaville, B. J., Weissman, M. M., Kleber, H., & Wilber, C. (1982). Heterogeneity of psychiatric diagnosis in treated opiate addicts. Archives of General Psychiatry, 39, 161–168.PubMedGoogle Scholar
  122. Sahakian, B. J., Elliot, R., Low, N., Mehta, M., Clark, R. T., & Pozniak, A. L. (1995). Neuropsychological deficits in tests of executive function in asymptomatic and symptomatic HIV-1 seropositive men.Psychological Medicine, 25, 1233–1246.PubMedGoogle Scholar
  123. Satz, P. (1993). Brain reserve capacity on symptom onset after brain injury: A formulation and review of evidence for threshold theory. Neuropsychology, 7, 273–295.Google Scholar
  124. Satz, P., Morgenstern, H., Miller, E. N., Seines, O. A., McArthur, J. C., Cohen, B. A., Wesch, J., Becker, J.T., Jacobsen, L., D’Elia, L. F., van Gorp, W., & Visscher, B. (1993). Low education as a possible risk factor for cognitive abnormalities in HIV-1: Findings from the Multicenter AIDS Cohort Study(MACS). Journal of Acquired Immune Deficiency Syndrome, 6, 503–511.Google Scholar
  125. Schmitt, F. A., Bigley, J. W., McKinnis, R., Logue, P. E., Evans, R. W., Drucker, J. L., & the AZT Collaborative Working Group. (1988). Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex. New England Journal of Medicine, 319, 1573–1578.PubMedGoogle Scholar
  126. Seines, O. A., Miller, E., McArthur, J., Gordon, B., Muñoz, A., Sheridan, K., Fox, R., Saah, A. J., & the Multicenter AIDS Cohort Study. (1990). HIV-1 infection: No evidence of cognitive decline during the asymptomatic stages. Neurology, 40, 204–208.Google Scholar
  127. Seines, O. A., Galai, N., Bacellar, H., Miller, E. N., Becker, J. T., Wesch, J., van Gorp, W., & McArthur, J. C.(1995). Cognitive performance after progression to AIDS: A longitudinal study from the Multicenter AIDS Cohort Study. Neurology, 45, 267–275.Google Scholar
  128. Sewell, D. D., Jeste, D. V., Atkinson, J. H., Heaton, R. K., Hesselink, J. R., Wiley, C., Thai, L., Chandler, J.L., Grant, I., & the San Diego HIV Neurobehavioral Research Center Group. (1994). HIV-associated psychosis: A study of 20 cases. American Journal of Psychiatry, 151, 237–242.PubMedGoogle Scholar
  129. Sonnerborg, A. B., Ehrnst, A. C., Bergdahl, S. K., Pehrson, P. O., Skoldenberg, B. R., & Strannegard, O. O.(1988). HIV isolation from cerebrospinal fluid in relation to immunological deficiency and neurological symptoms. AIDS, 2, 89–93.PubMedGoogle Scholar
  130. Stern, Y., Marder, K., Bell, K., Chen, J., Dooneief, G., Goldstein, S., Mindry, D., Richards, M., Sano, M.,Williams, J., Gorman, J., Ehrhardt, A., & Mayeux, R. (1991). Multidisciplinary assessment of homo-sexual men with and without human immunodeficiency virus infection. III. Neurologic and neuropsychological findings. Archives of Neurology, 48, 131–138.Google Scholar
  131. Stern, R. A., Arruda, J. E., Somerville, J. A., Cohen, R. A., Boland, R. J., Stein, M. D., & Martin, E. M.(1998). Neurobehavioral functioning in asymptomatic HIV-1 infected women. Journal of the International Neuropsychological Society, 4, 172–178.PubMedGoogle Scholar
  132. Stout, J. C., Ellis, R. J., Jernigan, T. L., Archibald, S. L., Abramson, I., Wolfson, T., McCutchan, J. A.,Wallace, M. R., Atkinson, J. H., Grant, I., & the HNRC Group. (1998). Progressive cerebral volumeloss in human immunodeficiency virus infection: A longitudinal volumetric MRI study. Archives of Neurology, 55, 161–168.PubMedGoogle Scholar
  133. Tracey, I., Carr, C. A., Guimaraes, A. R., Worth, J. L., Navia, B. A., & Gonzalez, R. G. (1996). Brain choline-containing compounds are elevated in HIV-positive patients before the onset of AIDS dementia complex: A proton magnetic resonance spectroscopic study. Neurology, 46, 783–788.PubMedGoogle Scholar
  134. United Nations Programme on HIV/AIDS, and World Health Organization. (1998). AIDS epidemic update: December 1998. Geneva: Author.Google Scholar
  135. United Nations Programme on HIV/AIDS, and World Health Organization. (2000). Report on the global HIV/AIDS epidemic. Geneva: Author.Google Scholar
  136. US Department of Labor. (1991). Dictionary of occupational titles (4th ed.). Washington, DC: US Government Printing Office.Google Scholar
  137. van der Horst, C. M., Saag, M. S., Cloud, G. A., Hamill, R. J., Graybill, J. R., Sobel, J. D., Johnson, P. C.,Tuazon, C. U., Kerkering, T., Moskovitz, B. L., Powderly, W. G., & Dismukes, W. E. (1997). Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group[see comments]. New England Journal of Medicine, 337, 15–21.PubMedGoogle Scholar
  138. Van Dyck, C. H., McMahon, T. J., Rosen, M. I., O’Malley, S. S., O’Connor, P. G., Lin, C. H., Pearsall, H. R.,Woods, S. W., & Kosten, T. R. (1997). Sustained-release methylphenidate for cognitive impairment in HIV-1-infected drug abusers: A pilot study. Journal of Neuropsychiatry and Clinical Neuro-sciences, 9, 29–36Google Scholar
  139. van Gorp, W., Satz, P., Hinkin, C., Seines, O., Miller, E., McArthur, J., Cohen, B., & Paz, D. (1991).Metacognition in HIV-1 seropositive asymptomatic individuals: Self-ratings versus objective neuropsychological performance. Journal of Clinical and Experimental Neuropsychology, 13, 812–819.PubMedGoogle Scholar
  140. van Gorp, W. G., Mandelkern, M. A., Gee, M., Hinkin, C. H., Stern, C. E., Paz, D. K., Dixon, W., Evans, G.,Flynn, F., Frederick, C. J., Ropchan, J. R., & Blahd, W. H. (1992). Cerebral metabolic dysfunction in AIDS: Findings in a sample with and without dementia. Journal of Neuropsychiatry and Clinical Neurosciences, 4, 280–287.PubMedGoogle Scholar
  141. van Gorp, W. G., Miller, E. N., Marcotte, T. D., Dixon, W., Paz, D., Seines, O., Wesch, J., Becker, J. T.,Hinkin, C. H., Mitrushina, M., Satz, P., Weisman, J. D., & Stenquist, P. K. (1994). The relationship between age and cognitive impairment in HIV-1 infection: Findings from the Multicenter AIDS Cohort Study and a clinical cohort. Neurology, 44, 929–935.PubMedGoogle Scholar
  142. Weis, S., Haug, H., & Budka, H. (1993). Neuronal damage in the cerebral cortex of AIDS brains: Amorphometric study. Acta Neuropathologica (Berlin), 85(2), 185–189.PubMedGoogle Scholar
  143. White, D. A., Heaton, R. K., & Monsch, A. U. (1995). Neuropsychological studies of asymptomatic Human Immunodeficiency Virus-Type 1-infected individuals. Journal of the International Neuropsychological Society, 1, 304–315.PubMedGoogle Scholar
  144. Wiley, C. A., & Achim, C. (1995). Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome Ann Neurol, 37:140Google Scholar
  145. Wiley, C. A., & Achim, C. (1994). Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome Annals of Neurology, 36, 673–676.PubMedGoogle Scholar
  146. Wiley, C. A., Schrier, R. D., Denaro, F. J., Nelson, J. A., Lampert, P. W., & Oldstone, M. B. (1986a).Localization of cytomegalovirus proteins and genome during fulminant central nervous system infection in an AIDS patient. Journal of Neuropathology and Experimental Neurology, 45, 127–139.PubMedGoogle Scholar
  147. Wiley, C. A., Schrier, R. D., Nelson, J. A., Lampert, P. W., & Oldstone, M. B. (1986b). Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proceedings of the National Academy of Sciences USA, 83, 7089–7093.Google Scholar
  148. Wiley, C., Masliah, E., Morey, M., Lemere, C., DeTeresa, R., Grafe, M., Hansen, L., & Terry, R. (1991).Neocortical damage during HIV infection. Annals of Neurology, 29, 651–657.PubMedGoogle Scholar
  149. Wilkie, F. L., Eisdorfer, C., Morgan, R., Loewenstein, D. A., & Szapocznik, J. (1990). Cognition in early human immunodeficiency virus infection. Archives of Neurology, 47, 433–440.PubMedGoogle Scholar
  150. Wilkins, J. W., Robertson, K. R., Snyder, C. R., Robertson, W. K., van der Horst, C., & Hall, C. D. (1991).Implications of self-reported cognitive and motor dysfunction in HIV-positive patients. American Journal of Psychiatry, 148, 641–643.PubMedGoogle Scholar
  151. Williams, J. B., Rabkin, J. G., Remien, R. H., Gorman, J. M., & Ehrhardt, A. A. (1991). Multidisciplinary baseline assessment of homosexual men with and without human immunodeficiency virus infection. II. Standardized clinical assessment of current and lifetime psychopathology. Archives of General Psychiatry, 48, 124–130.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2001

Authors and Affiliations

  • Thomas D. Marcotte
    • 1
  • Igor Grant
    • 2
  • J. Hampton Atkinson
    • 2
  • Robert K. Heaton
    • 1
  1. 1.HIV Neurobehavioral Research CenterUniversity of California—San DiegoSan DiegoUSA
  2. 2.HIV Neurobehavioral Research CenterUniversity of California—San Diego, and Psychiatry Service, San Diego Veterans Affairs Healthcare SystemSan DiegoUSA

Personalised recommendations